Willone Lim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Willone Lim has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Lau Bee Theng
Faculty of Engineering, Computing and Science, Swinburne University of Technology, Kuching, Sarawak, Malaysia
5 shared publications Fakir M Amirul Islam
School of Health Sciences, Swinburne University of Technology, Melbourne, Australia
2 shared publications- Fakir Mohammad Amirul Islam
Affiliations School of Health Sciences, Swinburne University of Technology, Australia, Organization for Rural Community Development (ORCD), Narail, Bangladesh
2 shared publications - Basel Al Bishtawi
Department of Mechanical, Materials, and Manufacturing Engineering, Faculty of Science and Engineering, University of Nottingham Malaysia , 43500 Semenyih
1 shared publication Caslon Chua
1 shared publication- Caslon Chua
School of Science, Computing and Emerging Technologies, Swinburne University of Technology, Hawthorn, Victoria, Australia
1 shared publication
Latest Publications
- 23 December 2024
- Published by Springer Nature in Journal of Technology in Behavioral Science
- Vol. 10 (3) , 613-623
Sociodemographic Factors Associated with Cyberbullying Experience and Practice Among Youths in Malaysia
- 23 December 2024
- Published by Springer Nature in Journal of Technology in Behavioral Science
- Vol. 10 (3) , 613-623
Sociodemographic Factors Associated with Cyberbullying Experience and Practice Among Youths in Malaysia
- Top Cited PapersOpen Access
- 20 January 2024
- Published by Elsevier in Computers & Security
- Vol. 139
Future of generative adversarial networks (GAN) for anomaly detection in network security: A review
- 20 January 2024
- Published by Elsevier in Computers & Security
- Vol. 139
Top Cited PapersOpen AccessFuture of generative adversarial networks (GAN) for anomaly detection in network security: A review
- Open Access
- 24 April 2023
- Published by Springer Nature in European Journal of Drug Metabolism and Pharmacokinetics
- Vol. 48 (3) , 221-240
Role of Cytochrome P450 2C9 in COVID-19 Treatment: Current Status and Future Directions
The major human liver drug metabolising cytochrome P450 (CYP) enzymes are downregulated during inflammation and infectious disease state, especially during coronavirus disease 2019 (COVID-19) infection. The influx of proinflammatory cytokines, known as a ‘cytokine storm’, during severe COVID-19 leads to the downregulation of CYPs and triggers new cytokine release, which further dampens CYP expression. Impaired drug metabolism, along with the inevitable co-administration of drugs or ‘combination therapy’ in patients with COVID-19 with various comorbidities, could cause drug–drug interactions, thus worsening the disease condition. Genetic variability or polymorphism in CYP2C9 across different ethnicities could contribute to COVID-19 susceptibility. A number of drugs used in patients with COVID-19 are inducers or inhibitors of, or are metabolised by, CYP2C9, and co-administration might cause pharmacokinetic and pharmacodynamic interactions. It is also worth mentioning that some of the COVID-19 drug interactions are due to altered activity of other CYPs including CYP3A4. Isoniazid/rifampin for COVID-19 and tuberculosis co-infection; lopinavir/ritonavir and cobicistat/remdesivir combination therapy; or multi-drug therapy including ivermectin, azithromycin, montelukast and acetylsalicylic acid, known as TNR4 therapy, all improved recovery in patients with COVID-19. However, a combination of CYP2C9 inducers, inhibitors or both, and plausibly different CYP isoforms could lead to treatment failure, hepatotoxicity or serious side effects including thromboembolism or bleeding, as observed in the combined use of azithromycin/warfarin. Further, herbs that are CYP2C9 inducers and inhibitors, showed anti-COVID-19 properties, and in silico predictions postulated that phytochemical compounds could inhibit SARS-CoV-2 virus particles. COVID-19 vaccines elicit immune responses that activate cytokine release, which in turn suppresses CYP expression that could be the source of compromised CYP2C9 drug metabolism and the subsequent drug–drug interaction. Future studies are recommended to determine CYP regulation in COVID-19, while recognising the involvement of CYP2C9 and possibly utilising CYP2C9 as a target gene to tackle the ever-mutating SARS-CoV-2.
- 24 April 2023
- Published by Springer Nature in European Journal of Drug Metabolism and Pharmacokinetics
- Vol. 48 (3) , 221-240
Open AccessRole of Cytochrome P450 2C9 in COVID-19 Treatment: Current Status and Future Directions
The major human liver drug metabolising cytochrome P450 (CYP) enzymes are downregulated during inflammation and infectious disease state, especially during coronavirus disease 2019 (COVID-19) infection. The influx of proinflammatory cytokines, known as a ‘cytokine storm’, during severe COVID-19 leads to the downregulation of CYPs and triggers new cytokine release, which further dampens CYP expression. Impaired drug metabolism, along with the inevitable co-administration of drugs or ‘combination therapy’ in patients with COVID-19 with various comorbidities, could cause drug–drug interactions, thus worsening the disease condition. Genetic variability or polymorphism in CYP2C9 across different ethnicities could contribute to COVID-19 susceptibility. A number of drugs used in patients with COVID-19 are inducers or inhibitors of, or are metabolised by, CYP2C9, and co-administration might cause pharmacokinetic and pharmacodynamic interactions. It is also worth mentioning that some of the COVID-19 drug interactions are due to altered activity of other CYPs including CYP3A4. Isoniazid/rifampin for COVID-19 and tuberculosis co-infection; lopinavir/ritonavir and cobicistat/remdesivir combination therapy; or multi-drug therapy including ivermectin, azithromycin, montelukast and acetylsalicylic acid, known as TNR4 therapy, all improved recovery in patients with COVID-19. However, a combination of CYP2C9 inducers, inhibitors or both, and plausibly different CYP isoforms could lead to treatment failure, hepatotoxicity or serious side effects including thromboembolism or bleeding, as observed in the combined use of azithromycin/warfarin. Further, herbs that are CYP2C9 inducers and inhibitors, showed anti-COVID-19 properties, and in silico predictions postulated that phytochemical compounds could inhibit SARS-CoV-2 virus particles. COVID-19 vaccines elicit immune responses that activate cytokine release, which in turn suppresses CYP expression that could be the source of compromised CYP2C9 drug metabolism and the subsequent drug–drug interaction. Future studies are recommended to determine CYP regulation in COVID-19, while recognising the involvement of CYP2C9 and possibly utilising CYP2C9 as a target gene to tackle the ever-mutating SARS-CoV-2.
- Open Access
- 19 December 2022
- Published by Qeios Ltd
Review of: "Participatory budgeting for public involvement in environmental sustainability at a Thai university"
This article covers on a very interesting and important topic. It is certainly important to include understanding on the active role of university students in environmental sustainability projects and how the University as whole getting involved in p...
- 19 December 2022
- Published by Qeios Ltd
Open AccessReview of: "Participatory budgeting for public involvement in environmental sustainability at a Thai university"
This article covers on a very interesting and important topic. It is certainly important to include understanding on the active role of university students in environmental sustainability projects and how the University as whole getting involved in p...
- 28 November 2022
- Published by Springer Nature in Education and Information Technologies
- Vol. 28 (6) , 6869-6925
Cyberbullying Awareness Intervention in Digital and Non-digital Environment for Youth: Current Knowledge
- 28 November 2022
- Published by Springer Nature in Education and Information Technologies
- Vol. 28 (6) , 6869-6925
Cyberbullying Awareness Intervention in Digital and Non-digital Environment for Youth: Current Knowledge
- 17 September 2021
- Published by Springer Nature
- p. 213-221
A Review: How Does ICT Affect the Health and Well-Being of Teenagers in Developing Countries
- 17 September 2021
- Published by Springer Nature
- p. 213-221
A Review: How Does ICT Affect the Health and Well-Being of Teenagers in Developing Countries
- Open Access
- 6 April 2021
- Published by European Alliance for Innovation n.o. in EAI Endorsed Transactions on Pervasive Health and Technology
- Vol. 7 (27) , e4
Do information and communication technologies influence skills, competencies, health and well-being of teenagers? Current evidence
INTRODUCTION: Information and Communication Technologies are deemed to be a significant influence on teenagers’ development. It is important for studies to be conducted to assess the underlying influence of ICT on the teenager age group.OBJECTIVES: The aim of this paper is to review whether ICT influences teenagers’ skills, competencies, health and well-being based on previous studies.METHODS: Articles from 2015 to 2020 were selected for analysis to identify the influences on teenagers.RESULTS: Computer and mobile devices offer opportunities to improve literacy in digital skills and competencies. It is also evident that teenagers are prone to risks of getting musculoskeletal symptoms as a result of excessive use of such devices, and it also leads to unforeseen illnesses such as depression in the case of teenager’s well-being.CONCLUSION: Adopting ICT may have beneficial implications for teenagers, but it can pose more adverse effects on their development when used excessively.
- 6 April 2021
- Published by European Alliance for Innovation n.o. in EAI Endorsed Transactions on Pervasive Health and Technology
- Vol. 7 (27) , e4
Open AccessDo information and communication technologies influence skills, competencies, health and well-being of teenagers? Current evidence
INTRODUCTION: Information and Communication Technologies are deemed to be a significant influence on teenagers’ development. It is important for studies to be conducted to assess the underlying influence of ICT on the teenager age group.OBJECTIVES: The aim of this paper is to review whether ICT influences teenagers’ skills, competencies, health and well-being based on previous studies.METHODS: Articles from 2015 to 2020 were selected for analysis to identify the influences on teenagers.RESULTS: Computer and mobile devices offer opportunities to improve literacy in digital skills and competencies. It is also evident that teenagers are prone to risks of getting musculoskeletal symptoms as a result of excessive use of such devices, and it also leads to unforeseen illnesses such as depression in the case of teenager’s well-being.CONCLUSION: Adopting ICT may have beneficial implications for teenagers, but it can pose more adverse effects on their development when used excessively.